Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory biomarkers and statins.

Luis Miguel Blanco-Colio1, José Tuñón, José Luis Martín-Ventura

  • 1Vascular Research Lab, Department of Cardiology, Fundacion Jimenez Diaz, Autonoma University, Madrid, Spain.

Drugs of Today (Barcelona, Spain : 1998)
|May 11, 2005
PubMed
Summary

Atherosclerosis is an inflammatory disease. This review explores inflammatory markers like C-reactive protein (CRP) and their modulation by statins (HMG-CoA reductase inhibitors) for cardiovascular disease prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytochrome b<sub>5</sub> reductase-3 overexpression reduces renal damage associated to intravascular hemolysis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Chronic kidney disease progression in glomerular diseases: is hematuria a key risk factor?

Pediatric nephrology (Berlin, Germany)·2026
Same author

Vitamin D in the prevention of left ventricular remodelling after an acute myocardial infarction: a randomized clinical trial.

Scientific reports·2026
Same author

Alirocumab Attenuated Plaque Inflammation and PCSK9-Induced Proinflammatory Signalling in M1 Macrophages Independently of Lipid Lowering.

Biomolecules·2026
Same author

SOCS1 Mimetic Peptide Enhances Empagliflozin Improvement on Kidney Damage in the Type 2 Diabetes Mouse Model BTBR ob/ob.

International journal of molecular sciences·2026
Same author

Loss of energy homeostasis contributes to hepatic damage development in sickle cell disease.

Molecular metabolism·2026

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Pharmacology

Background:

  • Atherosclerosis is increasingly recognized as an inflammatory disorder.
  • Elevated inflammatory molecules are observed in individuals at high risk for acute coronary events.
  • Understanding these markers aids in disease pathogenesis and therapeutic strategies.

Purpose of the Study:

  • To review current inflammatory markers used in assessing cardiovascular risk.
  • To analyze the therapeutic modulation of these markers by 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins).
  • To discuss the future potential of novel biomarkers in cardiovascular disease prevention and treatment.

Main Methods:

  • Literature review of inflammatory markers in atherosclerosis.

Related Experiment Videos

  • Analysis of studies investigating the effects of HMG-CoA reductase inhibitors on inflammatory markers.
  • Exploration of emerging technologies for biomarker discovery.

    • Main Results:

    • C-reactive protein (CRP), CD40 ligand, adhesion molecules, and chemokines are key inflammatory markers.
    • HMG-CoA reductase inhibitors demonstrate modulation of these inflammatory markers.
    • Current therapeutic interventions show promise in managing inflammatory aspects of atherosclerosis.

    Conclusions:

    • Inflammatory markers play a crucial role in understanding atherosclerosis.
    • Statins offer a therapeutic approach to modulate inflammation in cardiovascular disease.
    • Future advancements in biomarker discovery will enhance cardiovascular disease prevention and treatment strategies.